Austin, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Venous Stents Market Size & Growth Analysis: According to SNS Insider, the global Venous Stents Market size was valued at USD 1.36 billion in 2025 and ...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz., Jan. 6, 2026 ...
December 4, 2025—Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company’s non–drug-eluting mechanical scaffold. The data were ...
Objective: This study aims to develop an interpretable machine learning model for predicting post-operative iliac venous stent occlusion risk. Results: In independent testing-set validation, the ...
FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient ...
BD (NYSE: BDX) + today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study. AGILITY, an FDA investigational device exemption (IDE) study, evaluates ...
Introduction: Venous Stent migration to the cardiopulmonary system is a rare complication of endovascular stenting. Most reported stent embolizations originate from central thoracic veins, upper ...
Exertional lower extremity pain due to arterial insufficiency is uncommon in the young. In this case report we present a 34-year-old, previously healthy male with sudden onset left lower limb pain ...
Background: Endovascular treatment of aortoiliac occlusive disease is currently limited to kissing iliac stents with poor long-term outcomes. We developed an AortoIliac Fenestrated (AIFEN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results